NEW YORK (GenomeWeb News) – Horizon Discovery has licensed human genetic modeling technology for use in cancer research from Italy's University of Torino Medical School, the company said today.

The firm will pay the university undisclosed fees for sub-licensing control of the related patent estate.

The patented technology, developed at Torino's Department of Oncological Sciences, is related to the use of panels of engineered isogenic human cell lines that model genetic mutations found in cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.